FindTrial
Sign In

The application of Iris fluorescein angiography in normal and diabetic retinopathy patients

The application of Iris fluorescein angiography in normal and diabetic retinopathy patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018003
Enrollment
Unknown
Registered
2018-08-26
Start date
2018-08-19
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

1:20-39 years old
2:40-59 years old
3:60-79 years old
4:Diabetic patients with norma fundus
5:nonproliferlative diabetic retinopathy
6:proliferlative diabetic retinopathy

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. normal people, no other eye disorders; 2. diabetic patients.

Exclusion criteria

Exclusion criteria: 1. already have a treatment,such as laser and anti-VEGF therapy; 2. other eye disorders: AMD, PCV, glaucoma; 3. IFA and FFA.

Design outcomes

Primary

MeasureTime frame
Iris fluorescein angiography;—

Countries

China

Contacts

Public ContactLongli Zhang

Tianjin Medical University Eye Hospital

zhanglonglieye@126.com+86 13820891312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026